» Articles » PMID: 15367668

Histone Deacetylases 5 and 9 Govern Responsiveness of the Heart to a Subset of Stress Signals and Play Redundant Roles in Heart Development

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2004 Sep 16
PMID 15367668
Citations 291
Authors
Affiliations
Soon will be listed here.
Abstract

The adult heart responds to stress signals by hypertrophic growth, which is often accompanied by activation of a fetal cardiac gene program and eventual cardiac demise. We showed previously that histone deacetylase 9 (HDAC9) acts as a suppressor of cardiac hypertrophy and that mice lacking HDAC9 are sensitized to cardiac stress signals. Here we report that mice lacking HDAC5 display a similar cardiac phenotype and develop profoundly enlarged hearts in response to pressure overload resulting from aortic constriction or constitutive cardiac activation of calcineurin, a transducer of cardiac stress signals. In contrast, mice lacking either HDAC5 or HDAC9 show a hypertrophic response to chronic beta-adrenergic stimulation identical to that of wild-type littermates, suggesting that these HDACs modulate a specific subset of cardiac stress response pathways. We also show that compound mutant mice lacking both HDAC5 and HDAC9 show a propensity for lethal ventricular septal defects and thin-walled myocardium. These findings reveal central roles for HDACs 5 and 9 in the suppression of a subset of cardiac stress signals as well as redundant functions in the control of cardiac development.

Citing Articles

Anticancer efficacy of Spiruchostatin A: current insights into histone deacetylase inhibition and oncologic applications.

Ibrahim S, Khan M, Khurram I, Ghani M, Sharifi-Rad J, Calina D Eur J Med Res. 2025; 30(1):169.

PMID: 40082963 PMC: 11907871. DOI: 10.1186/s40001-025-02401-0.


Enzyme-independent functions of HDAC3 in the adult heart.

Qian S, Zhang C, Li W, Song S, Lin G, Cheng Z bioRxiv. 2025; .

PMID: 39803453 PMC: 11722435. DOI: 10.1101/2024.12.29.630635.


The molecular mechanisms of cardiac development and related diseases.

Li Y, Du J, Deng S, Liu B, Jing X, Yan Y Signal Transduct Target Ther. 2024; 9(1):368.

PMID: 39715759 PMC: 11666744. DOI: 10.1038/s41392-024-02069-8.


Epigenetics in Heart Failure.

Ho J, Jou E, Khong P, Foo R, Sia C Int J Mol Sci. 2024; 25(22).

PMID: 39596076 PMC: 11593553. DOI: 10.3390/ijms252212010.


The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?.

Spallotta F, Illi B Biomedicines. 2024; 12(11).

PMID: 39595195 PMC: 11591585. DOI: 10.3390/biomedicines12112631.


References
1.
Lu J, McKinsey T, Nicol R, Olson E . Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci U S A. 2000; 97(8):4070-5. PMC: 18151. DOI: 10.1073/pnas.080064097. View

2.
Naya F, Wu C, Richardson J, Overbeek P, Olson E . Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development. 1999; 126(10):2045-52. DOI: 10.1242/dev.126.10.2045. View

3.
Passier R, Zeng H, Frey N, Naya F, Nicol R, McKinsey T . CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest. 2000; 105(10):1395-406. PMC: 315462. DOI: 10.1172/JCI8551. View

4.
Kirchhefer U, Schmitz W, Scholz H, Neumann J . Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc Res. 1999; 42(1):254-61. DOI: 10.1016/s0008-6363(98)00296-x. View

5.
Sparrow D, Miska E, Langley E, Kotecha S, Towers N, Spohr G . MEF-2 function is modified by a novel co-repressor, MITR. EMBO J. 1999; 18(18):5085-98. PMC: 1171579. DOI: 10.1093/emboj/18.18.5085. View